Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(18):1373-1374; doi:10.1093/jnci/93.18.1373
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Fintor, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fintor, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 18, 1373-1374, September 19, 2001
© 2001 Oxford University Press

NEWS

New Montreal Gene Centers Boost Basic, Clinical Cancer Research

Lou Fintor

Canadian cancer patients are expected to be among the biggest beneficiaries of two new major genetic research centers slated to open in Montreal this fall.

The formation of the two distinct but complementary centers signals a major government investment in both translational "bench-to-bedside" cancer research and laboratory genome technology. These two new endeavors are designed to make many novel gene therapy clinical trials available for the first time in Canada as well as to strengthen Quebec’s position as a major international biotechnology player.

"In order to be able . . . [Full Text of this Article]

Clinical Trial Niche

Complementary Genome Center


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?